Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2023-07-07 00:00:00 ET · period of report 2023-07-05 · accession 0001104659-23-079114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-07 | 2023-07-05 | MBIO | ROSENWALD LINDSAY A MD | Dir | A - Grant | $0.00 | +7,246 | 60.5K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.0001 | 2023-07-05 | A | A | 7,246 | $0.00 | 60,525 | D | — | — | (F2) Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. (F1) The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date. (F3) Includes restricted share units, which vest over various time periods. |